development (Page 2)

Zhanna Hapanovich TRACON Pharmaceuticals (OTC:TCON) said it is discontinuing development of its oncology drug candidate envafolimab after a key clinical trial failed to meet its primary endpoint and will concentrate instead on exploring strategic alternatives for the company. TRACON said that the study, ENVASARC, failed to meet its primary endpointContinue Reading

This post is co-written with Jhanvi Shriram and Ketaki Shriram from Krikey. Krikey AI is revolutionizing the world of 3D animation with their innovative platform that allows anyone to generate high-quality 3D animations using just text or video inputs, without needing any prior animation experience. At the core of KrikeyContinue Reading